Hospital Profile
Name | Venice Regional Bayfront Health |
---|
Type | Acute Care Hospital |
---|
Location | 540 The Rialto, Venice, Florida |
---|
Ownership | Proprietary |
---|
Emergency Services | Yes |
---|
Medicare ID (CCN) | 100070 |
Patients' Experience Survey:
Overall Rating of the Hospital:
Willingness to Recommend Hospital:
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Venice Regional Bayfront Health from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
NPI Number | 1760427157 |
Organization Name | VENICE HMA LLC |
Doing Business As | SHOREPOINT HEALTH VENICE |
Address | 540 The Rialto, Venice, FL 34285 |
Hospital Type | General Acute Care Hospital |
Phone Number | 941-483-7773 |
News Archive
Report highlights 80 programs aimed at improving maternal, child health in developing world
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
Cardica initiates enrollment in MicroCutter surgical stapling study in Europe
Cardica, Inc. today announced that the first patients have been enrolled and discharged from the first two investigative sites in a European clinical study to evaluate its MicroCutter surgical cutting/stapling devices for transections, resections and anastomoses during gastrointestinal surgical procedures.
Imaging Diagnostic Systems to showcase CT Laser Breast imaging system at FIME 2011
Imaging Diagnostic Systems, Inc., a pioneer in optical breast imaging announced today that it will be exhibiting its CT Laser Breast imaging (CTLM) system at the FIME 2011 conference August 10-12, 2011 in Miami Beach, Florida. IDSI's Head of Clinical Research, Dr Jose Cineros will be a feature speaker at the exhibition.
Read more Medical News
› Verified 4 days ago
Structural Quality Measures:
Able to receive lab results electronically | No |
Able to track patients' lab results, tests, and referrals electronically between visits | No |
News Archive
Report highlights 80 programs aimed at improving maternal, child health in developing world
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
Cardica initiates enrollment in MicroCutter surgical stapling study in Europe
Cardica, Inc. today announced that the first patients have been enrolled and discharged from the first two investigative sites in a European clinical study to evaluate its MicroCutter surgical cutting/stapling devices for transections, resections and anastomoses during gastrointestinal surgical procedures.
Imaging Diagnostic Systems to showcase CT Laser Breast imaging system at FIME 2011
Imaging Diagnostic Systems, Inc., a pioneer in optical breast imaging announced today that it will be exhibiting its CT Laser Breast imaging (CTLM) system at the FIME 2011 conference August 10-12, 2011 in Miami Beach, Florida. IDSI's Head of Clinical Research, Dr Jose Cineros will be a feature speaker at the exhibition.
Read more News
› Verified 4 days ago